Bioactivation of vitamin D consists of two sequential hydroxylation steps to produce 1α, 25-dihydroxyvitamin D 3 . It is clear that the second or 1α-hydroxylation step is carried out by a single enzyme, 25-hydroxyvitamin D 1α-hydroxylase CYP27B1. However, it is not certain what enzyme or enzymes are responsible for the initial 25-hydroxylation. An excellent case has been made for vitamin D 25-hydroxylase CYP2R1, but this hypothesis has not yet been tested. We have now produced Cyp2r1 −/− mice. These mice had greater than 50% reduction in serum 25-hydroxyvitamin D 3 . Curiously, the 1α,25-dihydroxyvitamin D 3 level in the serum remained unchanged. These mice presented no health issues. A double knockout of Cyp2r1 and Cyp27a1 maintained a similar circulating level of 25-hydroxyvitamin D 3 and 1α,25-dihydroxyvitamin D 3 . Our results support the idea that the CYP2R1 is the major enzyme responsible for 25-hydroxylation of vitamin D, but clearly a second, as-yet unknown, enzyme is another contributor to this important step in vitamin D activation. 25-Hydroxyvitamin D 1a-hydroxylase CYP27B1 (CYP27B1) has long been identified as the sole 25(OH)D 3 1α-hydroxylase in a number of species, including human (5), whereas the specific vitamin D 3 25-hydroxylase has yet to be elucidated. Many candidates have been proposed, but in vivo proof has yet to appear. Most of the potential 25-hydroxylases are primarily expressed in the liver, and all are members of the cytochrome P450 family (CYP2C11, CYP2D25, CYP27A1, CYP3A4, CYP2R1, and CYP2J2/3) (4). Among them, CYP27A1 and CYP2R1 are considered the most promising candidates for vitamin D 25-hydroxylation. CYP27A1, also known as the sterol 27-hydroxylase, is a key enzyme in bile acid formation (6, 7). Recombinant CYP27A1 is able to catalyze multiple oxidation reactions with broad substrate specificity in vitro (8) (9) (10) (11) (12) (13) (14) . However, it is a lowaffinity, high-capacity vitamin D 25-hydroxylase and is certainly involved in steroidogenesis. Ablation of Cyp27a1 in mouse disrupted cholesterol metabolism and bile acid synthesis severely but did not alter vitamin D metabolism (15, 16). Indeed, these animals had supranormal serum 25(OH)D 3 levels (15). Patients with cerebrotendinous xanthomatosis caused by mutations in the Cyp27a1 gene show dysfunctions that result from reduced bile acid production, but generally do not present vitamin D-related pathology (17, 18). These findings suggest that CYP27A1 is a minor factor, if it plays a role at all, in 25(OH)D 3 synthesis in vivo. CYP2R1 was recently identified as vitamin D 25-hydroxylase in mouse and human through the screening of a liver cDNA library from Cyp27a1-null mice (19). Heterologous expression of CYP2R1 in HEK cells, yeast, and Escherichia coli revealed that CYP2R1 catalyzes 25-hydroxylation of both vitamin D 3 and vitamin D 2 at similar rate, and much more efficiently than CYP27A1 (19-21). The clinical relevance of CYP2R1 as vitamin D 25-hydroxylase is from a handful of patients of Nigerian and Saudi Arabian decent having 25(OH)D 3 deficiency (22-26). These patients exhibited symptoms of vitamin D-dependent rickets. This condition appeared to mostly result from an amino acid mutation (Leu99Pro) that altered the CYP2R1 structure and abolished 25-hydroxylase activity (21), although other mutations have been reported (26).
Bioactivation of vitamin D consists of two sequential hydroxylation steps to produce 1α,25-dihydroxyvitamin D 3 . It is clear that the second or 1α-hydroxylation step is carried out by a single enzyme, 25-hydroxyvitamin D 1α-hydroxylase CYP27B1. However, it is not certain what enzyme or enzymes are responsible for the initial 25-hydroxylation. An excellent case has been made for vitamin D 25-hydroxylase CYP2R1, but this hypothesis has not yet been tested. We have now produced Cyp2r1 −/− mice. These mice had greater than 50% reduction in serum 25-hydroxyvitamin D 3 . Curiously, the 1α,25-dihydroxyvitamin D 3 level in the serum remained unchanged. These mice presented no health issues. A double knockout of Cyp2r1 and Cyp27a1 maintained a similar circulating level of 25-hydroxyvitamin D 3 and 1α,25-dihydroxyvitamin D 3 . Our results support the idea that the CYP2R1 is the major enzyme responsible for 25-hydroxylation of vitamin D, but clearly a second, as-yet unknown, enzyme is another contributor to this important step in vitamin D activation. 25-Hydroxyvitamin D 1a-hydroxylase CYP27B1 (CYP27B1) has long been identified as the sole 25(OH)D 3 1α-hydroxylase in a number of species, including human (5), whereas the specific vitamin D 3 25- hydroxylase has yet to be elucidated. Many candidates have been proposed, but in vivo proof has yet to appear. Most of the potential 25-hydroxylases are primarily expressed in the liver, and all are members of the cytochrome P450 family (CYP2C11, CYP2D25, CYP27A1, CYP3A4, CYP2R1, and CYP2J2/3) (4). Among them, CYP27A1 and CYP2R1 are considered the most promising candidates for vitamin D 25-hydroxylation. CYP27A1, also known as the sterol 27-hydroxylase, is a key enzyme in bile acid formation (6, 7) . Recombinant CYP27A1 is able to catalyze multiple oxidation reactions with broad substrate specificity in vitro (8) (9) (10) (11) (12) (13) (14) . However, it is a lowaffinity, high-capacity vitamin D 25-hydroxylase and is certainly involved in steroidogenesis. Ablation of Cyp27a1 in mouse disrupted cholesterol metabolism and bile acid synthesis severely but did not alter vitamin D metabolism (15, 16) . Indeed, these animals had supranormal serum 25(OH)D 3 levels (15). Patients with cerebrotendinous xanthomatosis caused by mutations in the Cyp27a1 gene show dysfunctions that result from reduced bile acid production, but generally do not present vitamin D-related pathology (17, 18) . These findings suggest that CYP27A1 is a minor factor, if it plays a role at all, in 25(OH)D 3 synthesis in vivo. CYP2R1 was recently identified as vitamin D 25-hydroxylase in mouse and human through the screening of a liver cDNA library from Cyp27a1-null mice (19) . Heterologous expression of CYP2R1 in HEK cells, yeast, and Escherichia coli revealed that CYP2R1 catalyzes 25-hydroxylation of both vitamin D 3 and vitamin D 2 at similar rate, and much more efficiently than CYP27A1 (19) (20) (21) . The clinical relevance of CYP2R1 as vitamin D 25-hydroxylase is from a handful of patients of Nigerian and Saudi Arabian decent having 25(OH)D 3 deficiency (22) (23) (24) (25) (26) . These patients exhibited symptoms of vitamin D-dependent rickets. This condition appeared to mostly result from an amino acid mutation (Leu99Pro) that altered the CYP2R1 structure and abolished 25-hydroxylase activity (21) , although other mutations have been reported (26) .
We have created Cyp2r1 −/− and Cyp2r1/Cyp27a1 doubleknockout mouse models and evaluated the physiological role of CYP2R1 in the vitamin D activation pathway. Our results strongly support the concept that CYP2R1 is a major contributor to 25-hydroxylation of vitamin D in vivo, but show there is another unidentified enzyme that participates in this important activation.
Results

Generation of Cyp2r1
−/− and Cyp2r1
A mouse embryonic stem cell clone carrying Cyp2r1-null allele, in which the entire Cyp2r1 gene spanning a 12.9-kb region on chromosome 7 was deleted and replaced with a lacZ reporter and selection cassette, was used to generate chimeras. Crossbreeding with C57BL/6 eventually established Cyp2r1 knockout mice (Fig.  1) . The offspring from heterozygous breeding pairs had no sex bias and followed Mendelian genetic distribution with 26% wildtype, 50% heterozygotes, and 24% knockout in 199 mice. The genotypes of stillborn pups and those dead before weaning were analyzed to be 22% wild-type, 54% heterozygotes, and 24% knockout among 45 bodies collected, confirming that Cyp2r1 ablation did not cause prenatal death. Double-knockout mice were generated by crossing Cyp2r1 −/− mice with the Cyp27a1 −/− strain. To whom correspondence should be addressed. E-mail: deluca@biochem.wisc.edu.
developmental or behavioral problems. The major organs including liver, kidney, heart, lung, thymus, spleen, small intestine, testis, and brain were weighed and compared with those isolated from age-and sex-matched wild-type animals. No anomalies were observed via visual examination, except for the enlarged livers in double-knockout mice, which were ∼35% larger, likely the result of Cyp27a1 ablation, as reported previously (16) . In our experience, Cyp27a1 −/− mice housed under the same conditions had enlarged livers (∼45%) as well. All animals had a stable serum calcium level of 9.9 mg/dL since weaning. The phosphorus level in serum decreased slightly from 12.3 mg/dL at 3-5 wk of age to 10.2 mg/dL on maturity and remained stable from then on in all mice. The serum concentration of parathyroid hormone was low (22 pg/mL), and there was no noticeable difference between wild-type and Cyp2r1 −/− mice. Both Cyp2r1 −/− and Cyp2r1
−/− mice were fertile and were able to produce as many normal-sized litters as wild-type mice. −/− mice compared with that of the wild-type, with a reduction of more than 50% ( Fig. 2 and Table 1 ). The serum level of 25(OH)D 3 in heterozygotes was somewhere in between but was close to that of the wild type; it seemed to catch up to the wild type at 14 wk. A marked two-to threefold increase in 25(OH)D 3 concentration was detected in Cyp27a1 −/− mice, which is consistent with an earlier report (15) . However, the Cyp2r1 (27) , remained comparable in all age groups and genotypes at 51-68 pg/mL ( Table 2 ). The normal serum concentration of 1,25(OH) 2 D 3 in Cyp2r1 −/− and Cyp2r1 −/− / Cyp27a1 −/− mice was further supported by the fact that the mice did not develop rickets in response to a rachitogenic high-calcium and low-phosphorus diet. At 4-6 wk of age, mice were switched to a purified diet containing 1.2% Ca/0.02% P. The 1.2% Ca/0.02% P diet is expected to produce rickets in the absence of vitamin D (28) . The serum calcium level of the mice on the diet steadily increased, whereas the phosphorus level quickly dropped, rendering the mice hypophosphatemic (Fig. 3) . However, the epiphyseal plates in the tibia from Cyp2r1 −/− and Cyp2r1 wild-type mice, whereas the Cyp27b1 −/− mice used as controls had very wide growth plates, which is characteristic of rickets (Fig. 4) . The Cyp27b1 −/− mice receiving a 1.2% Ca/0.02% P diet remained hypocalcemic and hypophosphatemic (Fig. 3) 5) . Note that the relative abundance of CYP2R1 transcripts is dependent on the reference gene used as normalizing standard, which may explain the different ratios seen in earlier reports (19, 29) . The CYP2R1 mRNA level was slightly higher than CYP27A1 in the liver, although the opposite trend has been reported (19) , probably because of variations in the strains. A 1.5-fold increase in CYP2R1 transcripts was observed in Cyp27a1
−/− mice in the liver, with less in the testis.
Discussion
We report the creation and characterization of Cyp2r1 −/− and Cyp2r1 −/− /Cyp27a1 −/− mice. The most striking feature of both knockout mice was the more than 50% reduction in serum 25(OH)D 3 level, whereas the circulating 1,25(OH) 2 (11, 13, 14) , they were trivial and were probably not able to carry out meaningful degradation of 25(OH)D 3 in vivo. Therefore, the high level of 25(OH)D 3 in Cyp27a1 −/− mice is unlikely a result of hindered catabolism. A more plausible explanation has been that Cyp27a1 ablation causes increased expression of the Cyp2r1 gene. Because Cyp2r1 −/− /Cyp27a1 −/− mice had dramatically reduced 25(OH)D 3 levels, similar to that of Cyp2r1 −/− mice, and the real-time PCR analysis indicated that the CYP2R1 transcript level in the liver was increased in Cyp27a1 −/− mice, it seems clear that CYP2R1 is the major, albeit not the only, vitamin D 25-hydroxylase.
CYP2R1 is highly conserved across vertebrate species (30) and shows no sexual dimorphism (19, 31) . An in vitro reconstituted P450 system has been used to demonstrate that CYP2R1 acts equally well on vitamin D 3 and vitamin D 2 (19) (20) (21) . The only known pathological condition associated with CYP2R1 disruption is the rare mutations identified in patients with 25(OH)D 3 deficiency and vitamin D-dependent rickets (22) (23) (24) (25) (26) . CYP2R1 is primarily expressed in liver and testis (19, 29, (32) (33) (34) . The former is consistent with liver being the major site of 25-hydroxylation, but its abundance in testis awaits further investigation to decipher the physiological relevance, although it has been linked to male reproduction, testicular cancer, and other testiculopathic conditions (33) (34) (35) . Cyp2r1 polymorphisms have been implicated in the variation of circulating 25(OH)D 3 concentrations (36) (37) (38) and as risk factors in type 1 diabetes and multiple sclerosis in humans (39) (40) (41) (42) .
Despite the significantly reduced 25(OH)D 3 level, Cyp2r1 ablation did not abolish the synthesis of 25(OH)D 3 , suggesting the presence of other vitamin D 25-hydroxylases. Some of the candidates hypothesized earlier have been deemed less likely to be the physiological vitamin D 25-hydroxylase, at least in humans. For example, CYP2C11, the first isolated enzyme that contains vitamin D 25-hydroxylation activity, is only found in rat and is only present in males, with its major function being testosterone hydroxylase (4) . Similarly, porcine CYP2D25 does not have a functionally related human ortholog. CYP2D6, the only P450 isoform of human CYP2D subfamily, exhibits no detectable vitamin D 25-hydroxylation activity despite 77% sequence identity (4) . The species specificity and sexual dimorphism makes them less relevant as potential 25-hyroxylases. In contrast, CYP27A1, the well-studied sterol 27-hydroxylase and the only mitochondrial enzyme with vitamin D 25-hydroxylase activity, has been cloned in rabbit, rat, and human (8, 9, (43) (44) (45) and was considered a strong candidate for some time. However, Cyp27a1-null mice showed a normal phenotype in the vitamin D activation pathway (15) . Over the years, the identification of the nuclear hormone response elements in the Cyp3a4 gene promoter has drawn attention to the most abundant P450 in human liver and intestine as a possible vitamin D 25-hydroxylase (46) (47) (48) (49) (50) , although the vitamin D receptor is undetectable in the liver (51) . CYP3A4 is a well-known xenobiotic-metabolizing enzyme and can act on approximately half of the drugs in use. Although CYP3A4 can hydroxylate vitamin D compounds in vitro (52, 53) , it is unclear whether it functions as a physiological 25-hydroxylase for vitamin D in vivo. Finally, rat CYP2J3, better known as the arachidonic acid epoxygenase (54) , has shown very high 25-hydroxylase activities toward vitamin D 3 and is mostly expressed in the liver (31) . CYP2J2, the human counterpart, is mainly involved in the cardiovascular system and intestinal metabolism of antihistamine drugs (55, 56) . Its 25-hydroxylase activity was much lower and seemed to favor vitamin D 2 over vitamin D 3 (57) . The potential contribution of CYP2J2 in vitamin D 25-hydroxylation in vivo is not known. With Cyp2r1
mice available, a screening of their liver cDNA library, similar to the one that was used to discover CYP2R1 (19) , may provide a way to identify the remaining vitamin D 25-hydroxylases.
Materials and Methods
Generation of Cyp2r1
−/− and Cyp2r1 −/− /Cyp27a1 −/− Mice. Two embryonic stem cell clones from Velocigene at Regeneron, which replaced a 12.9-kb span covering all 5 exons of Cyp2r1 gene on chromosome 7 with β-galactosidase coding sequence (lacZ) and neomycin selection cassette, were purchased through knockout mouse project repository (University of California Davis-CHORI), with 10% and 75% euploidy, respectively. The clone with 75% euploidy was used for blastocyst injection into pseudopregnant C57BL/6 albino females at University of Michigan Transgenic Animal Model Core for chimera production. The chimeric founders were transferred to the University of Wisconsin-Madison and crossbred with C57BL/6 females (Harlan). The Cyp2r1 −/− mice were generated by crossing F 1 heterozygotes. Offspring from generations F 3 through F 5 were used in the study. The Cyp2r1 Wild-type Cyp2r1 Jackson Laboratory. All mice were maintained on C57BL/6 background and fed a commercial chow diet [LabDiet 5015 (0.80% Ca/0.50% P) for breeders and 4 and 450 μL of CH 3 OH, with vortexing after the addition of each component. The supernatant was extracted with hexane and methyl t-butyl ether. The extracts were derivatized with 4-[2-(6,7-dimethoxy-4-methyl-3-oxo-3,4-dihydroquinoxalyl)ethyl]-1,2,4-triazoline-3,5-dione (DMEQ-TAD) (Key Synthesis) in ethyl acetate, as described previously (59) , and redissolved in 60 μL of 60% CH 3 OH/40% H 2 O. Triplicate 10 μL-aliquots of each serum extract were subjected to analysis, using an ACQUITY ultraperformance LC coupled to a TQ-S triple-quadrupole mass spectrometer in electrospray-positive mode (Waters). Chromatography was achieved using a 65-90% (vol/vol) CH 3 OH/H 2 O exponential gradient (curve 8) at a flow rate of 0.4 mL/min over the course of 5 min on a UPLC BEH-Phenyl column (1.7 μm, 2.1 × 50 mm, Waters). The UPLC solvents were supplemented with 0.1% formic acid and 2 mM ammonium acetate. Quantitation was performed using calibration curves generated with internal standards.
1,25(OH) 2 D 3 concentration was measured using a luciferase reporter assay with modifications (27) . Serum (100 μL) was extracted with Oasis MCX extraction cartridge (Waters), following the manufacturer's protocol. The CH 3 OH eluent was dried in a SpeedVac, and the residues were resuspended in CH 3 OH:C 2 H 5 OH (1:1) and filtered through a GHP Acrodisc filter (Pall).
The filtrate was dried in the SpeedVac, and the residues were redissolved in the same media used in the luciferase assay by continuous vortexing. (62) , 2.5 mL PBS, and 10 mM NADPH (final concentration). NADPH was omitted in the control reactions. The mixture was incubated at 37°C for 2.5 h on a shaker at 220 rpm and subjected to modified Bligh-Dyer extraction (63) , in which CHCl 3 was replaced with CH 2 Cl 2 . The CH 2 Cl 2 layer was dried down in a SpeedVac to less than 50 μL of oil and diluted in HPLC mobile phase of 97% hexane/3% isopropanol. The lipid extract was applied onto a straight phase column (ZORBAX SIL, 4.6 × 250 mm, Agilent) run in the same solvent. Fractions were collected, and the conversion rate of vitamin D 3 to 25(OH)D 3 was calculated from tritium count. The retention time of tritiated vitamin D 3 and 25(OH)D 3 was based on comigration with authentic compounds under the same condition monitored at 265 nm.
Analysis of Epiphyseal Plate. Mice at 4-6 wk of age were switched to a rachitogenic diet that contains essential vitamins and minerals in addition to the basal composition (64) but has imbalanced calcium and phosphorus content (1.2% Ca/0.02% P). The mice were maintained on the diet for 5-6 wk. Blood was collected weekly or every 2 wk for serum analysis. Mice were killed by CO 2 asphyxiation, and the tibia-fibula joint sections were isolated. The bones were split longitudinally, revealing epiphyseal plates, and stained briefly in 1% AgNO 3 . Cyp27b1 −/− mice were included in the study as positive controls, and most were terminated within 4 wk because of severe rickets.
Real-Time PCR Analysis. Twelve wild-type and 12 Cyp27a1 −/− mice including both sexes were killed by CO 2 asphyxiation and perfused with cold PBS. Tissues from liver, kidney, testis, and ovaries were immediately collected, submerged in Tri reagent (Molecular Research Center), flash-frozen in liquid N 2 , and stored at −80°C. RNA was isolated according to manufacturer's protocol. cDNA synthesis was performed using a high-capacity cDNA reverse transcription kit (Applied Biosystems). Real-time PCR reactions were carried out in duplicate on a StepOnePlus real-time PCR system, using Taqman gene expression assays (Applied Biosystems). β-Actin mRNA was used as normalizing standard. The assay IDs were Mm01159413_m1 for Cyp2r1, Mm00470430_m1 for Cyp27a1, and Mm00607939_s1 for β-actin. Cyp2r1 −/− mice were included as negative controls for CYP2R1 transcripts (C T > 40).
Statistical Analysis. Data were expressed as mean ± SD. Statistical differences between experimental groups were quantified by two-tailed Student t test.
